HEADER HYDROLASE/HYDROLASE INHIBITOR 25-JUL-17 5WKL TITLE 1.85 A RESOLUTION STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH TITLE 2 PIPERIDINE-BASED PEPTIDOMIMETIC INHIBITOR 17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PEPTIDASE C30 DOMAIN RESIDUES 3248-3553; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 GENE: ORF1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEASE, PROTEASE INHHIBITORS, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,K.P.BATTAILE,N.MEHZABEEN,A.C.G.KANKANAMALAGE,Y.KIM, AUTHOR 2 A.D.RATHNAYAKE,K.O.CHANG,W.C.GROUTAS REVDAT 3 04-OCT-23 5WKL 1 REMARK REVDAT 2 01-JAN-20 5WKL 1 REMARK REVDAT 1 04-APR-18 5WKL 0 JRNL AUTH A.C.GALASITI KANKANAMALAGE,Y.KIM,V.C.DAMALANKA, JRNL AUTH 2 A.D.RATHNAYAKE,A.R.FEHR,N.MEHZABEEN,K.P.BATTAILE,S.LOVELL, JRNL AUTH 3 G.H.LUSHINGTON,S.PERLMAN,K.O.CHANG,W.C.GROUTAS JRNL TITL STRUCTURE-GUIDED DESIGN OF POTENT AND PERMEABLE INHIBITORS JRNL TITL 2 OF MERS CORONAVIRUS 3CL PROTEASE THAT UTILIZE A PIPERIDINE JRNL TITL 3 MOIETY AS A NOVEL DESIGN ELEMENT. JRNL REF EUR J MED CHEM V. 150 334 2018 JRNL REFN ISSN 1768-3254 JRNL PMID 29544147 JRNL DOI 10.1016/J.EJMECH.2018.03.004 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2838) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 22761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1127 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.9535 - 3.6995 0.98 2732 145 0.1450 0.1699 REMARK 3 2 3.6995 - 2.9366 0.99 2686 149 0.1560 0.2139 REMARK 3 3 2.9366 - 2.5654 0.99 2710 142 0.1658 0.2246 REMARK 3 4 2.5654 - 2.3309 0.99 2697 138 0.1648 0.2341 REMARK 3 5 2.3309 - 2.1638 0.99 2703 132 0.1661 0.2225 REMARK 3 6 2.1638 - 2.0362 1.00 2717 152 0.1720 0.2421 REMARK 3 7 2.0362 - 1.9342 0.99 2691 148 0.1966 0.2553 REMARK 3 8 1.9342 - 1.8500 0.99 2698 121 0.2383 0.2723 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2376 REMARK 3 ANGLE : 1.072 3247 REMARK 3 CHIRALITY : 0.058 378 REMARK 3 PLANARITY : 0.007 409 REMARK 3 DIHEDRAL : 11.689 1358 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WKL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1000229190. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.25 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22772 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 46.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.68600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4RSP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG 3350, 100 MM BIS-TRIS, REMARK 280 200 MM MGCL2, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.62650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.04950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.62650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.04950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -18.63068 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 46.11256 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 622 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A 73 REMARK 465 ALA A 74 REMARK 465 PRO A 75 REMARK 465 MET A 305 REMARK 465 GLN A 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 47 CG OD1 OD2 REMARK 470 GLN A 48 CG CD OE1 NE2 REMARK 470 ASP A 51 CG OD1 OD2 REMARK 470 LYS A 70 CE NZ REMARK 470 ILE A 72 CG1 CG2 CD1 REMARK 470 ARG A 124 CD NE CZ NH1 NH2 REMARK 470 LYS A 155 CE NZ REMARK 470 GLU A 156 CD OE1 OE2 REMARK 470 MET A 189 CG SD CE REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 HIS A 194 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 197 CD OE1 NE2 REMARK 470 LEU A 198 CG CD1 CD2 REMARK 470 LYS A 201 CE NZ REMARK 470 LYS A 224 CE NZ REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 GLN A 241 CD OE1 NE2 REMARK 470 GLN A 249 CG CD OE1 NE2 REMARK 470 LYS A 257 CD CE NZ REMARK 470 GLN A 277 CG CD OE1 NE2 REMARK 470 LYS A 279 CE NZ REMARK 470 GLN A 280 CD OE1 NE2 REMARK 470 GLU A 290 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS A -1 O HOH A 501 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -132.37 55.09 REMARK 500 ALA A 220 16.36 -141.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 AVY A 401 REMARK 610 B3J A 402 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AVY A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B3J A 402 DBREF1 5WKL A 1 306 UNP A0A1L2E0X0_9BETC DBREF2 5WKL A A0A1L2E0X0 3248 3553 SEQADV 5WKL MET A -6 UNP A0A1L2E0X INITIATING METHIONINE SEQADV 5WKL HIS A -5 UNP A0A1L2E0X EXPRESSION TAG SEQADV 5WKL HIS A -4 UNP A0A1L2E0X EXPRESSION TAG SEQADV 5WKL HIS A -3 UNP A0A1L2E0X EXPRESSION TAG SEQADV 5WKL HIS A -2 UNP A0A1L2E0X EXPRESSION TAG SEQADV 5WKL HIS A -1 UNP A0A1L2E0X EXPRESSION TAG SEQADV 5WKL HIS A 0 UNP A0A1L2E0X EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER GLY LEU VAL LYS MET SEQRES 2 A 313 SER HIS PRO SER GLY ASP VAL GLU ALA CYS MET VAL GLN SEQRES 3 A 313 VAL THR CYS GLY SER MET THR LEU ASN GLY LEU TRP LEU SEQRES 4 A 313 ASP ASN THR VAL TRP CYS PRO ARG HIS VAL MET CYS PRO SEQRES 5 A 313 ALA ASP GLN LEU SER ASP PRO ASN TYR ASP ALA LEU LEU SEQRES 6 A 313 ILE SER MET THR ASN HIS SER PHE SER VAL GLN LYS HIS SEQRES 7 A 313 ILE GLY ALA PRO ALA ASN LEU ARG VAL VAL GLY HIS ALA SEQRES 8 A 313 MET GLN GLY THR LEU LEU LYS LEU THR VAL ASP VAL ALA SEQRES 9 A 313 ASN PRO SER THR PRO ALA TYR THR PHE THR THR VAL LYS SEQRES 10 A 313 PRO GLY ALA ALA PHE SER VAL LEU ALA CYS TYR ASN GLY SEQRES 11 A 313 ARG PRO THR GLY THR PHE THR VAL VAL MET ARG PRO ASN SEQRES 12 A 313 TYR THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS GLY SEQRES 13 A 313 SER VAL GLY TYR THR LYS GLU GLY SER VAL ILE ASN PHE SEQRES 14 A 313 CYS TYR MET HIS GLN MET GLU LEU ALA ASN GLY THR HIS SEQRES 15 A 313 THR GLY SER ALA PHE ASP GLY THR MET TYR GLY ALA PHE SEQRES 16 A 313 MET ASP LYS GLN VAL HIS GLN VAL GLN LEU THR ASP LYS SEQRES 17 A 313 TYR CYS SER VAL ASN VAL VAL ALA TRP LEU TYR ALA ALA SEQRES 18 A 313 ILE LEU ASN GLY CYS ALA TRP PHE VAL LYS PRO ASN ARG SEQRES 19 A 313 THR SER VAL VAL SER PHE ASN GLU TRP ALA LEU ALA ASN SEQRES 20 A 313 GLN PHE THR GLU PHE VAL GLY THR GLN SER VAL ASP MET SEQRES 21 A 313 LEU ALA VAL LYS THR GLY VAL ALA ILE GLU GLN LEU LEU SEQRES 22 A 313 TYR ALA ILE GLN GLN LEU TYR THR GLY PHE GLN GLY LYS SEQRES 23 A 313 GLN ILE LEU GLY SER THR MET LEU GLU ASP GLU PHE THR SEQRES 24 A 313 PRO GLU ASP VAL ASN MET GLN ILE MET GLY VAL VAL MET SEQRES 25 A 313 GLN HET AVY A 401 30 HET B3J A 402 30 HETNAM AVY (1R,2S)-2-{[N-({[4-BENZYL-1-(TERT-BUTOXYCARBONYL) HETNAM 2 AVY PIPERIDIN-4-YL]OXY}CARBONYL)-L-LEUCYL]AMINO}-1- HETNAM 3 AVY HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1- HETNAM 4 AVY SULFONIC ACID HETNAM B3J (1S,2S)-2-{[N-({[4-BENZYL-1-(TERT-BUTOXYCARBONYL) HETNAM 2 B3J PIPERIDIN-4-YL]OXY}CARBONYL)-L-LEUCYL]AMINO}-1- HETNAM 3 B3J HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1- HETNAM 4 B3J SULFONIC ACID HETSYN AVY BOUND FORM FORMUL 2 AVY C31 H48 N4 O10 S FORMUL 3 B3J C31 H48 N4 O10 S FORMUL 4 HOH *128(H2 O) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 PRO A 45 LEU A 49 5 5 HELIX 4 AA4 ASN A 53 MET A 61 1 9 HELIX 5 AA5 THR A 62 HIS A 64 5 3 HELIX 6 AA6 CYS A 203 ASN A 217 1 15 HELIX 7 AA7 SER A 229 ASN A 240 1 12 HELIX 8 AA8 THR A 248 GLY A 259 1 12 HELIX 9 AA9 ALA A 261 GLY A 275 1 15 HELIX 10 AB1 THR A 292 GLY A 302 1 11 SHEET 1 AA1 7 ASN A 77 LEU A 78 0 SHEET 2 AA1 7 PHE A 66 GLN A 69 -1 N VAL A 68 O LEU A 78 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 MET A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 92 N VAL A 36 SHEET 7 AA1 7 VAL A 80 GLN A 86 -1 N VAL A 81 O THR A 93 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 GLU A 169 1 O PHE A 162 N THR A 105 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N GLY A 152 O TYR A 164 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N SER A 116 O TYR A 153 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 GLU A 169 1 O PHE A 162 N THR A 105 SHEET 3 AA3 3 HIS A 175 SER A 178 -1 O SER A 178 N MET A 165 LINK SG CYS A 148 C19AAVY A 401 1555 1555 1.80 LINK SG CYS A 148 C19BB3J A 402 1555 1555 1.82 SITE 1 AC1 15 HIS A 41 THR A 62 HIS A 64 PHE A 143 SITE 2 AC1 15 CYS A 145 CYS A 148 HIS A 166 GLN A 167 SITE 3 AC1 15 MET A 168 GLU A 169 HIS A 175 ASP A 190 SITE 4 AC1 15 GLN A 192 B3J A 402 HOH A 564 SITE 1 AC2 16 THR A 62 HIS A 64 PHE A 143 CYS A 145 SITE 2 AC2 16 GLY A 146 SER A 147 CYS A 148 HIS A 166 SITE 3 AC2 16 GLN A 167 MET A 168 GLU A 169 HIS A 175 SITE 4 AC2 16 ASP A 190 GLN A 192 AVY A 401 HOH A 564 CRYST1 101.253 58.099 49.734 90.00 112.00 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009876 0.000000 0.003991 0.00000 SCALE2 0.000000 0.017212 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021687 0.00000